Northside Capital Management, LLC Pfizer Inc Transaction History

Northside Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$33.49 - $37.77 $225,186 - $253,965	-6,724 Closed	0 $0
Q4 2020 Jan 22, 2021	SELL	$33.47 - $42.56 $162,195 - $206,245	-4,846 Reduced 41.88%	6,724 $248,000
Q3 2019 Oct 11, 2019	SELL	$32.49 - $42.13 $90,192 - $116,952	-2,776 Reduced 19.35%	11,570 $416,000
Q1 2019 Apr 12, 2019	BUY	$37.5 - $41.2 $30,375 - $33,372	810 Added 5.98%	14,346 $609,000
Q4 2018 Jan 14, 2019	BUY	$38.47 - $43.86 $101,291 - $115,483	2,633 Added 24.15%	13,536 $591,000

Q3 2018 Oct 11, 2018	SELL	$34.47 - $41.81 $13,443 - $16,305	-390 Reduced 3.45%	10,903 $480,000
Q2 2018 Jul 11, 2018	SELL	$32.98 - $35.16 $71,005 - $75,699	-2,153 Reduced 16.01%	11,293 $410,000
Q1 2018 Apr 13, 2018	BUY	$31.91 - $37.02 $10,721 - $12,438	336 Added 2.56%	13,446 $477,000
Q4 2017 Jan 26, 2018	BUY	$33.26 - $35.29 $31,929 - $33,878	960 Added 7.9%	13,110 $475,000
Q3 2017 Oct 20, 2017	BUY	$31.0 - $34.15 $376,650 - $414,922	12,150	12,150 $434,000

3,158

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Northside Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Northside Capital Management, LLC with notifications on news.